Clinical Trial Update: Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.

View source ↗

Summary

This completed clinical trial evaluated plasma levels of the biomarkers GDF-9 and GDF-15 in patients with Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Ankara Education and Research Hospital | Conditions: Polycystic Ovary Syndrome | Status: COMPLETED